User profiles for Jira Chansaenroj
 | Jira ChansaenrojChulalongkorn University Verified email at chula.ac.th Cited by 1299 |
[HTML][HTML] Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries
S Khongwichit, J Chansaenroj, C Chirathaworn… - Journal of Biomedical …, 2021 - Springer
Chikungunya virus (CHIKV) is a re-emerging mosquito-borne human pathogen that causes
chikungunya fever, which is typically accompanied by severe joint pain. In Asia, serological …
chikungunya fever, which is typically accompanied by severe joint pain. In Asia, serological …
[HTML][HTML] Cytokines and chemokines in chikungunya virus infection: protection or induction of pathology
C Chirathaworn, J Chansaenroj, Y Poovorawan - Pathogens, 2020 - mdpi.com
Chikungunya virus (CHIKV) infection has been commonly detected in tropical countries.
The clinical manifestations of CHIKV infection are similar to those of rheumatoid arthritis. …
The clinical manifestations of CHIKV infection are similar to those of rheumatoid arthritis. …
Detection of severe acute respiratory syndrome coronavirus 2 and influenza viruses based on CRISPR-Cas12a
…, K Khongnomnan, J Chansaenroj… - Experimental …, 2021 - journals.sagepub.com
Due to the common symptoms of COVID-19, patients are similar to influenza-like illness.
Therefore, the detection method would be crucial to discriminate between SARS-CoV-2 and …
Therefore, the detection method would be crucial to discriminate between SARS-CoV-2 and …
[HTML][HTML] Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients
J Chansaenroj, R Yorsaeng, N Posuwan, J Puenpa… - Scientific reports, 2021 - nature.com
This study monitored the long-term immune response to severe acute respiratory syndrome
coronavirus (SARS-CoV)-2 infection in patients who had recovered from coronavirus …
coronavirus (SARS-CoV)-2 infection in patients who had recovered from coronavirus …
[HTML][HTML] Large-scale outbreak of Chikungunya virus infection in Thailand, 2018–2019
S Khongwichit, J Chansaenroj, T Thongmee… - PloS one, 2021 - journals.plos.org
Between 2018 and 2019, the incidence of chikungunya was approximately 15,000 cases
across 60 provinces in Thailand. Here, the clinical presentations in chikungunya, emergent …
across 60 provinces in Thailand. Here, the clinical presentations in chikungunya, emergent …
Effects of boosted mRNA and adenoviral‐vectored vaccines on immune responses to omicron BA. 1 and BA. 2 following the heterologous CoronaVac/AZD1222 …
…, P Pakchotanon, J Chansaenroj… - Journal of Medical …, 2022 - Wiley Online Library
The coronavirus 2019 omicron variant has surged rapidly and raises concerns about immune
evasion even in individuals with complete vaccination, because it harbors mutations. Here …
evasion even in individuals with complete vaccination, because it harbors mutations. Here …
[HTML][HTML] Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020–2022
…, P Rattanakomol, N Saengdao, J Chansaenroj… - Archives of …, 2023 - Springer
The global COVID-19 pandemic, caused by the novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was first detected in China in December 2019. To date, there …
coronavirus 2 (SARS-CoV-2), was first detected in China in December 2019. To date, there …
[HTML][HTML] Immunogenicity following two doses of the BBIBP-CorV vaccine and a third booster dose with a viral vector and mRNA COVID-19 vaccines against delta and …
J Chansaenroj, N Suntronwong, S Kanokudom… - Vaccines, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) booster vaccination is being comprehensively
evaluated globally due to waning immunity and the emergence of new severe acute respiratory …
evaluated globally due to waning immunity and the emergence of new severe acute respiratory …
[HTML][HTML] Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: A cross-sectional survey from October 2022 to …
J Chansaenroj, N Suntronwong, S Kanokudom… - Scientific Reports, 2023 - nature.com
Seroprevalence studies on SARS-CoV-2 are essential for estimating actual prevalence rates
of infection and vaccination in communities. This study evaluated infection rates based on …
of infection and vaccination in communities. This study evaluated infection rates based on …
[HTML][HTML] Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens
S Kanokudom, J Chansaenroj, N Suntronwong… - International Journal of …, 2023 - Elsevier
Objectives To report the safety and immunogenicity profile of a protein subunit vaccine (Covovax
TM ) given as a third (booster) dose to individuals primed with different primary vaccine …
TM ) given as a third (booster) dose to individuals primed with different primary vaccine …
